We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

266 hedge funds and large institutions have $4.24B invested in Immunogen Inc in 2023 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 67 increasing their positions, 72 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

426% more capital invested

Capital invested by funds: $805M → $4.24B (+$3.43B)

304% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 25

93% more call options, than puts

Call options by funds: $69.3M | Put options by funds: $35.8M

40% more funds holding

Funds holding: 190266 (+76)

7% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 72

Holders
266
Holders Change
+76
Holders Change %
+40%
% of All Funds
4.18%
Holding in Top 10
13
Holding in Top 10 Change
+13
Holding in Top 10 Change %
% of All Funds
0.2%
New
101
Increased
67
Reduced
72
Closed
25
Calls
$69.3M
Puts
$35.8M
Net Calls
+$33.4M
Net Calls Change
+$21.4M
Name Holding Trade Value Shares
Change
Change in
Stake
CM
176
Caption Management
Oklahoma
$566K +$354K +30,000 New
MFS
177
Mirabella Financial Services
United Kingdom
$540K +$338K +28,630 New
Envestnet Asset Management
178
Envestnet Asset Management
Illinois
$540K +$338K +28,616 New
LCM
179
Legato Capital Management
California
$528K +$330K +27,983 New
Commonwealth Equity Services
180
Commonwealth Equity Services
Massachusetts
$517K -$1.79M -151,840 -85%
JCM
181
Jacobi Capital Management
Pennsylvania
$500K -$230K -19,500 -42%
AQR Capital Management
182
AQR Capital Management
Connecticut
$489K +$13.4K +1,134 +5%
LB
183
Leo Brokerage
Texas
$472K
Cambridge Investment Research Advisors
184
Cambridge Investment Research Advisors
Iowa
$442K -$330K -27,968 -54%
NICM
185
Neo Ivy Capital Management
New York
$439K +$275K +23,256 New
Royal Bank of Canada
186
Royal Bank of Canada
Ontario, Canada
$413K -$485K -41,041 -65%
AIP
187
Ameritas Investment Partners
Nebraska
$378K +$51.9K +4,398 +28%
Belvedere Trading
188
Belvedere Trading
Illinois
$375K +$116K +9,824 +98%
VEA
189
Virtus ETF Advisers
New York
$366K -$474K -40,181 -67%
EFM
190
E Fund Management
China
$342K -$703K -59,530 -77%
HT
191
HAP Trading
New York
$340K +$212K +17,995 New
TFM
192
TFC Financial Management
Massachusetts
$339K
Mackenzie Financial
193
Mackenzie Financial
Ontario, Canada
$336K +$14.2K +1,200 +7%
GAM
194
Gotham Asset Management
New York
$330K +$207K +17,511 New
PCM
195
Perkins Capital Management
Minnesota
$325K -$50.8K -4,300 -20%
RJA
196
Raymond James & Associates
Florida
$319K -$336K -28,482 -63%
Creative Planning
197
Creative Planning
Kansas
$317K +$199K +16,819 New
Northwestern Mutual Wealth Management
198
Northwestern Mutual Wealth Management
Wisconsin
$316K -$177 -15 -0.1%
Verition Fund Management
199
Verition Fund Management
Connecticut
$293K +$183K +15,513 New
TCWM
200
Total Clarity Wealth Management
Illinois
$290K +$181K +15,346 New

IMGN Hedge Fund Activity: Q2 2023 in Review

266 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2023, worth a combined $4.24B — up 426% from $805M a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new IMGN positions and 25 closed out — a net gain of 76 holders — while 67 added to existing stakes and 72 trimmed.

The largest buyer was Redmile Group, adding an estimated $114M. The largest seller was RA Capital Management, cutting an estimated $231M.

  • 266 institutional investors held Immunogen Inc (IMGN) as of Q2 2023, up from 190 in Q1 2023.
  • Funds reported $4.24B of Immunogen Inc stock for Q2 2023, up 426% quarter-over-quarter.
  • 101 funds opened new Immunogen Inc positions in Q2 2023 and 25 closed out, a net change of +76 holders.
  • The largest Immunogen Inc buyer in Q2 2023 was Redmile Group, an estimated $114M added.
  • The largest Immunogen Inc seller in Q2 2023 was RA Capital Management, an estimated $231M sold.

Based on aggregated 13F filings for Q2 2023.